Tyra Biosciences Inc (TYRA) — Financial Flexibility Index
Tyra Biosciences Inc (TYRA) has a Financial Flexibility Index of -1.01x as of December 2025. Free cash flow of $-23.57 Million (operating CF $-23.62 Million minus capex $57.00K) represents -1% of total liabilities ($23.43 Million). Check TYRA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tyra Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Tyra Biosciences Inc across 7 annual periods. See TYRA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tyra Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Tyra Biosciences Inc. For the full company profile including market capitalisation, see Tyra Biosciences Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.05x | $-95.00 Million | $-95.14 Million | $23.43 Million | ▼ -19.7% |
| 2024 | -3.39x | $-69.11 Million | $-69.77 Million | $20.41 Million | ▼ -48.1% |
| 2023 | -2.29x | $-49.37 Million | $-50.14 Million | $21.59 Million | ▲ +61.6% |
| 2022 | -5.95x | $-49.73 Million | $-50.28 Million | $8.35 Million | ▼ -28.0% |
| 2021 | -4.65x | $-23.08 Million | $-23.75 Million | $4.96 Million | ▼ -1750.4% |
| 2020 | -0.25x | $-7.45 Million | $-7.76 Million | $29.65 Million | ▲ +49.0% |
| 2019 | -0.49x | $-2.60 Million | $-2.62 Million | $5.27 Million | — |